FATIMA MENDOZA: Open Payments
NPI 1033387329 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 90 payments from 16 companies in 2025. Trend: 2023 $780 · 2024 $1,965 · 2025 $1,561
Food & beverage: $1,561
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $279 |
| AstraZeneca Pharmaceuticals LP | 13 | $273 |
| PFIZER INC. | 16 | $186 |
| Lilly USA, LLC | 11 | $172 |
| ABBVIE INC. | 9 | $149 |
| Phathom Pharmaceuticals, Inc. | 7 | $123 |
| Astellas Pharma US Inc | 4 | $75 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Eisai Inc. | 2 | $42 |
Products named: AIRSUPRA, Wegovy, VOQUEZNA, MOUNJARO, Ozempic, JARDIANCE, NURTEC ODT, Veozah.
Industry payments across TX — which companies pay providers there.
